Structures by: Li G. C.
Total: 19
4,5,6-trimethyl-2-((phenylsulfonyl)amino)pyrimidine
C13H15N3O2S
Acta Crystallographica Section E (2006) 62, 9 o4154-o4155
a=7.7014(19)Å b=8.831(2)Å c=10.849(3)Å
α=83.894(4)° β=70.965(4)° γ=78.118(4)°
2-(2-Chloropyrimidin-4-yl)-3,5,6,7,8,9-hexahydro-2<i>H</i>-1,2,4- triazolo[4,3-<i>a</i>]azepin-3-one
C11H12ClN5O
Acta Crystallographica Section E (2008) 64, 10 o1928
a=8.6810(16)Å b=14.718(3)Å c=9.4251(17)Å
α=90.00° β=92.359(3)° γ=90.00°
4-Phenyl-1,2,3,4-tetrahydropyrimido[1,2-a]benzimidazol-2-one
C16H13N3O
Acta Crystallographica Section E (2008) 64, 11 o2143
a=13.606(3)Å b=7.5674(15)Å c=24.578(5)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(4-nitrophenyl)-2-(trifluoromethyl)pyrimido[1,2-<i>a</i>]benzimidazole- 3-carboxylate
C20H13F3N4O4
Acta Crystallographica Section E (2008) 64, 12 o2469
a=8.4075(5)Å b=26.6904(14)Å c=9.0559(5)Å
α=90.00° β=111.027(2)° γ=90.00°
1-Allyl-3-amino-1<i>H</i>-pyrazole-4-carboxylic acid
C7H9N3O2
Acta Crystallographica Section E (2008) 64, 12 o2264
a=8.966(2)Å b=8.531(2)Å c=10.266(2)Å
α=90.00° β=95.57(3)° γ=90.00°
1,3-Bis(4-methylbenzyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C20H20N2O2
Acta Crystallographica Section E (2010) 66, 1 o193
a=9.4182(19)Å b=10.102(2)Å c=10.448(2)Å
α=66.25(3)° β=80.79(3)° γ=71.18(3)°
6-(Trifluoromethyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione monohydrate
C5H5F3N2O3
Acta Crystallographica Section E (2010) 66, 7 o1699
a=5.0250(8)Å b=7.0460(10)Å c=20.769(2)Å
α=90.00° β=91.300(7)° γ=90.00°
2-Amino-4,6-dimethylpyrimidin-1-ium 1-oxo-2,6,7-trioxa-1λ^5^-phosphabicyclo[2.2.2]octane-4-carboxylate
C6H10N3,C5H6O6P
Acta Crystallographica Section E (2010) 66, 7 o1528
a=9.5080(13)Å b=6.1870(8)Å c=23.974(2)Å
α=90.00° β=99.611(5)° γ=90.00°
2-Amino-1<i>H</i>-benzoimidazol-3-ium 4,4,4-trifluoro-1,3-dioxo-1-phenylbutan-2-ide
C7H8N3,C10H6F3O2
Acta Crystallographica Section E (2008) 64, 12 o2460
a=16.755(3)Å b=10.552(2)Å c=18.497(4)Å
α=90.00° β=90.00° γ=90.00°
1-Benzoyl-4-(2-nitrophenyl)semicarbazide
C14H12N4O4
Acta Crystallographica Section E (2010) 66, 5 o1113
a=4.655(2)Å b=15.020(7)Å c=10.005(5)Å
α=90.00° β=97.954(7)° γ=90.00°
Ethyl 6-[4-(dimethylamino)phenyl]-4-hydroxy-2-oxo-\ 4-(trifluoromethyl)hexahydropyrimidine-5-carboxylate
C16H20F3N3O4
Acta Crystallographica Section E (2010) 66, 5 o1083
a=13.319(4)Å b=7.923(2)Å c=16.530(5)Å
α=90.00° β=92.720(5)° γ=90.00°
1,3-Bis(4-methoxybenzyl)-6-methylpyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C21H22N2O4
Acta Crystallographica Section E (2010) 66, 7 o1858
a=8.4133(9)Å b=9.9290(10)Å c=21.407(3)Å
α=90.00° β=91.614(4)° γ=90.00°
<i>rac</i>-Ethyl 4-hydroxy-6-(2-hydroxyphenyl)-2-oxo-4-(trifluoromethyl)perhydropyrimidine- 5-carboxylate
C14H15F3N2O5
Acta Crystallographica Section E (2010) 66, 7 o1651
a=12.0940(15)Å b=8.6650(10)Å c=14.3110(18)Å
α=90.00° β=93.987(6)° γ=90.00°
6-Hydroxy-4-(pyridin-3-yl)-5-(2-thienylcarbonyl)-6-trifluoromethyl- 3,4,5,6-tetrahydropyrimidin-2(1<i>H</i>)-one
C15H12F3N3O3S
Acta Crystallographica Section E (2010) 66, 11 o2852
a=29.694(3)Å b=5.9710(8)Å c=17.6910(16)Å
α=90.00° β=95.223(8)° γ=90.00°
1,3-Bis(4-<i>tert</i>-butylbenzyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C26H32N2O2
Acta Crystallographica Section E (2011) 67, 7 o1608
a=7.5742(18)Å b=12.191(3)Å c=13.080(3)Å
α=88.643(4)° β=84.809(4)° γ=78.381(4)°
Ethyl 6-(4-fluorophenyl)-4-hydroxy-2-oxo-4-trifluoromethyl- 1,3-diazinane-5-carboxylate monohydrate
C14H14F4N2O4,H2O1
Acta Crystallographica Section E (2011) 67, 7 o1704-o1705
a=10.0196(9)Å b=12.1718(12)Å c=14.3037(14)Å
α=98.463(7)° β=103.642(8)° γ=104.400(9)°
1-(4-<i>tert</i>-Butylbenzyl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione
C15H18N2O2
Acta Crystallographica Section E (2012) 68, 4 o1047
a=20.853(7)Å b=10.013(4)Å c=13.893(5)Å
α=90.00° β=94.915(6)° γ=90.00°
6-Benzyloxy-2-phenylpyridazin-3(2<i>H</i>)-one
C17H14N2O2
Acta Crystallographica Section E (2012) 68, 6 o1646
a=7.390(4)Å b=9.385(5)Å c=10.587(6)Å
α=106.618(7)° β=97.489(6)° γ=101.098(9)°
C22H18N12O6Zn
C22H18N12O6Zn
Inorganic chemistry (2016) 55, 2 549-551
a=16.141(3)Å b=10.667(2)Å c=17.303(8)Å
α=90.00° β=120.17(2)° γ=90.00°